3543 results for «53»
3543 results
Percutaneous treatment of pure aortic regurgitation: a new indication
21 Sep 2023 – From AICT-AsiaPCR 2023
Analyse the case of an 83-year-old male patient with history of HT, parkinson's disease and minor stroke, who presented with worsening exertional SOB, LVEF 55-60 %, dilated LV, mild MR, and severe AR, and study the different options to treat aortic regurgitation.
Valve-in-valve - LIVE case
21 Sep 2023 – From AICT-AsiaPCR 2023
An 84-year-old man, with a history of 23 Carpentier-Edwards in 2004, PPM in 2013, AF on warfarin and impaired LV function (40 %), presented with severe symptomatic stenosis of the surgical bioprosthesis.
A 23 Navitor was implanted without predilatation and with post-dilatation under cerebral protection (Sentinel).
Closure was...
Calcified bifurcation lesion - LIVE case
22 Sep 2023 – From AICT-AsiaPCR 2023
A 59-year-old female patient with type 2 DM, dyslipidaemia, hypothyroidism and impaired LV function (39%) presented with multivessel disease. RCA PCI was performed 3 days ago.
The prox and mid LAD showed a severe calcified lesion including the diagonal. The lesion was prepared using a 1.25 Rotaglide™ ('single-person'...
Abstracts - Coronary interventions - Session 4
07 Oct 2022 – From AICT-AsiaPCR 2022
Complex CTO - LIVE case
22 Sep 2023 – From AICT-AsiaPCR 2023
View the case of an 82-year-old man with history of CABG in 2003 (LIMA LAD, VG RCA, VG CX), PCIs on VG RCA in 2021, PCIs VG-CX in 2022, PPM in 2023 with preserved LV function, and follow the retrograde approach of calcified CX CTO using...
AICT-AsiaPCR 2023 Awards Ceremony
22 Sep 2023 – From AICT-AsiaPCR 2023
With a record number of abstracts and clinical cases submitted this year, the winners of these AICT-AsiaPCR 2023 awards have done an excellent job, as the selection process was extremely rigorous. Find out more about the finalists, their reactions and the works that led them to...
Clinical cases - Structural interventions - Session 7
07 Oct 2022 – From AICT-AsiaPCR 2022
AICT-AsiaPCR 2023 Closing Ceremony
22 Sep 2023 – From AICT-AsiaPCR 2023
As AICT-AsiaPCR 2023 draws to a close, it's time to say thank you to the 950 participants and all those who helped make the conference a success, both on stage and behind the scenes.
Revolutionising coronary calcium treatment: unleashing the potential of intravascular lithotripsy
21 Sep 2023 – From AICT-AsiaPCR 2023
Over the last five years, we have learned that there is a new tool for treating calcium, the greatest enemy of interventional cardiology, which can take various forms: intravascular lithotripsy. In this session, look at how to master this technique in different scenarios, from eccentric calcified...
A hybrid approach in complex PCI: can DES and DCB be complementary?
21 Sep 2023 – From AICT-AsiaPCR 2023
Watch this case-based session to follow discussion about how to choose between DES & DCB, how both can be complementary in diffuse disease as well as in complex PCI, and how physiology and imaging can help guiding PCI, and follow a patient's treatment live.
Clinical cases - Structural interventions - Session 9
07 Oct 2022 – From AICT-AsiaPCR 2022
Leave nothing behind: DCB-only PCI strategy - How DCB evidence has changed today's practice?
22 Sep 2023 – From AICT-AsiaPCR 2023
This session offers an opportunity to stay informed about the recent developments in the International DCB Consensus Group, gain insights into the latest clinical data and real-world experiences related to drug-coated balloon (DCB)-only PCI, understand the safety aspects of DCB in managing complex PCI cases, and...
The importance of SEE-PREP-TREAT in left main bifurcation
22 Sep 2023 – From AICT-AsiaPCR 2023
This session is recommended for you if you are seeking insights into the advantages of using IVUS imaging over visual assessment for better outcomes in left main bifurcation procedures. Discuss with experts the benefits of using RotaCUT in lesion preparation for left main bifurcation and explore...
Clinical cases - Coronary interventions - Session 8
07 Oct 2022 – From AICT-AsiaPCR 2022
Essentials of lifetime management in patient undergoing TAVI using novel balloon expandable Myval Octacor THV
22 Sep 2023 – From AICT-AsiaPCR 2023
This session with a LIVE case provides information about the Octacor transcatheter heart valve technology, highlighting its procedural and clinical benefits. It also covers the Octalign technique, which ensures precise alignment of commissural and coronary access, and discusses the precise sizing, positioning, and deployment of Octacor THV.
Rapid-fire - Other SHD interventions
18 Feb 2024 – From PCR Tokyo Valves 2024
Structural heart disease might present unusual complications during intervention. In this series of rapid-fire case submissions, learn about intervention on a pregnant patient, complete heart block post TAVR, and TAVR on a nonagerian female.
CAD and TAVI
18 Feb 2024 – From PCR Tokyo Valves 2024
What is the clinical impact of CAD in TAVR recipients and how best to treat it? Through this session, gain insight on how to determine optimal CAD assessment in TAVR recipients, learn the timing of coronary revascularisation pre-TAVR, and understand the exact assessment and treatment of...
TEER for primary mitral regurgitation
18 Feb 2024 – From PCR Tokyo Valves 2024
What are the current indications and future perspectives of using TEER for primary mitral regurgitation? Join this session if you want to gain insight into anatomical evaluation before TEER, learn the procedural strategy for complex primary mitral regurgitation, and explore the specific features of both MitraClip...
TAVI optimisation
18 Feb 2024 – From PCR Tokyo Valves 2024
Consult this series of slides to enhance your understanding of TAVI optimisation through selected studies for PCR Tokyo Valves 2024. Learn about the prognostic value of right ventricle dysfunction after TAVR, explore a risk model in dialysis patients following TAVR, and explore the impact of age...
Managing aortic stenosis in patients with longer life expectancy
18 Feb 2024 – From PCR Tokyo Valves 2024
Consult this session to understand what knowledge is needed for discussions with patients concerning lifetime management of valve disease, gain insight into the importance of predictable and precise commissural and coronary alignment for lifetime management, and learn about the indication of TAV-in-TAV and THV explant.